SFX by Ex Libris Inc.

Title:	Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods
Source:	Gene Therapy [0969-7128] Sastry, L yr:2002

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hämmerling, G J J. "Antigen processing and presentation - Towards the Millennium." Immunological reviews 172 (1999): 5-9.
description	2.	qi Chen, X. "Telomerase RNA as a detection marker in the serum of breast cancer patients." Clinical cancer research 6.10 (2000): 3823-3826.
description	3.	Hitt, D C C. "A flow cytometric protocol for titering recombinant adenoviral vectors containing the green fluorescent protein." Molecular Biotechnology 14.3 (2000): 197-203.
description	4.	Sastry, L. "Certification assays for HIV-1-based vectors: Frequent passage of gag sequences without evidence of replication-competent viruses." Molecular therapy 8.5 (2003): 830-9.
description	5.	Yang, L. "Targeting lentiviral vectors to specific cell types in vivo." Proceedings of the National Academy of Sciences of the United States of America 103.31 (2006): 11479-84.
description	6.	Flake, Alan W W. "Optimized large-scale production of high titer lentivirus vector pseudotypes." Journal of virological methods 122.2 (2004): 131-9.
description	7.	Wada, T. "Light microscopic observations on pollen and anther development in rice (Oryza sativa L.). I. Stages from pollen mother cells to tetrads." 日本作物学会紀事 59.4 (1990): 769-777.
description	8.	Scarlata, S. "Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions." Journal of molecular biology 277.2 (1998): 161-9.
description	9.	Cresswell, P. "The nature of the NMC class I peptide loading complex." Immunological reviews 172 (1999): 21-.
description	10.	Bottley, G. "Flow cytometric detection of adenoviruses and intracellular adenovirus proteins." Methods in molecular medicine 130 (2007): 205-13.
description	11.	Nestle, M. "An Extracellular Nuclease from Serratia marcescens I. PURIFICATION AND SOME PROPERTIES OF THE ENZYME." The Journal of biological chemistry 244.19 (1969): 5213-5218.
description	12.	Ni, Y.. "Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector." The journal of gene medicine 7.6 (2005): 818-834.
description	13.	Rosenberg, Eric S. "Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia." Science 278.5342 (1997): 1447-1450.
description	14.	An, Irvin S Y S. "Optimization and Functional Effects of Stable Short Hairpin RNA Expression in Primary Human Lymphocytes via Lentiviral Vectors." Molecular therapy 14.4 (2006): 494-504.
description	15.	Bartosch, B. "Strategies for retargeted gene delivery using vectors derived from lentiviruses." Current gene therapy 4.4 (2005): 427-43.
description	16.	Larocque, D. "QUAKING KH domain proteins as regulators of glial cell fate and myelination." RNA biology 2.2 (2005): 37-40.
description	17.	Trono, D. "Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo." Nature biotechnology 15.9 (1997): 871-5.
description	18.	Knight, Christopher G. "Unraveling adaptive evolution: how a single point mutation affects the protein coregulation network." Nature genetics 38.9 (2006): 1015-1022.
description	19.	Lever, J. "Lentiviral vectors." Journal of biomedical science 11.4: 439-449.
description	20.	Rosenberg, E. "Immune control of HIV-1 after early treatment of acute infection." Nature 407.6803 (2000): 523-526.